Drug search by name

Sprycel and Pulmonary arterial hypertension

Result of checking the interaction of drug Sprycel and disease Pulmonary arterial hypertension for safety when used together.

Check result:

Sprycel <> Pulmonary arterial hypertension

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Dasatinib can increase the risk of developing pulmonary arterial hypertension (PAH) which may occur any time after treatment initiation, including after more than 1 year of treatment. Manifestations may include dyspnea, fatigue, hypoxia, and fluid retention. PAH may be reversible with treatment discontinuation. Caution should be exercised in patients with underlying cardiopulmonary disease. If PAH develops, treatment should be discontinued.

Sprycel

Generic Name: dasatinib

Brand Name: Sprycel

Synonyms: n.a.

What is Sprycel?